Prof. Dr. Volkan Gürkan

Malignant Bone Tumors (Bone Sarcomas)

Malignant Bone Tumors (Bone Sarcomas)

Scientific information about malignant bone tumors (bone sarcomas), diagnostic methods, surgical treatment options, and follow-up processes.

Malignant bone tumors are types of cancer that originate in bone tissue and have the potential to spread to surrounding tissues. Also called bone sarcomas, these tumors can occur in different age groups and may exhibit different clinical characteristics depending on the type of tumor.

Osteosarcoma, Ewing sarcoma, and chondrosarcoma are among the main malignant bone tumors. These tumors can manifest as bone pain, swelling, limited movement, or fractures due to bone weakening.

Primary bone cancers originating in the bone are different from metastatic tumors that spread to the bone from other organs. This distinction is important for diagnosis and treatment planning.

Diagnosis and Evaluation

In the evaluation of malignant bone tumors, the patient's complaints, physical examination findings, and radiological examinations are considered together.

Imaging methods such as X-ray, magnetic resonance imaging (MRI), and computed tomography (CT) are used. Biopsy and pathological examination are usually required for a definitive diagnosis.

It is important that the biopsy is properly planned, considering that it may affect subsequent surgical treatment options.

Treatment Approaches

Treatment for malignant bone tumors is determined by the type, location, size, and extent of the tumor, as well as the patient's overall health characteristics.

The goal of surgical treatment is to remove the tumor with appropriate surgical margins. In suitable patients, limb-sparing surgery and post-tumor bone reconstruction may be performed.

While chemotherapy is a significant part of treatment for osteosarcoma and Ewing sarcoma, surgical treatment is the primary approach for many types of chondrosarcoma. Radiotherapy may also be included in the treatment plan for some patients.

Diagnosis, treatment, and follow-up processes are evaluated multidisciplinarily with the participation of relevant specialties such as orthopedics and traumatology, medical oncology, radiation oncology, radiology, and pathology.